Seres Therapeutics Statistics

Total Valuation

MCRB has a market cap or net worth of $68.65 million. The enterprise value is $99.40 million.

Market Cap	68.65M
Enterprise Value	99.40M

Important Dates

The last earnings date was Wednesday, May 7, 2025, before market open.

Earnings Date	May 7, 2025
Ex-Dividend Date	n/a

Share Statistics

MCRB has 8.72 million shares outstanding. The number of shares has increased by 32,735.87% in one year.

Current Share Class	8.72M
Shares Outstanding	8.72M
Shares Change (YoY)	+32,735.87%
Shares Change (QoQ)	+101,641.53%
Owned by Insiders (%)	0.58%
Owned by Institutions (%)	23.13%
Float	6.42M

Valuation Ratios

The trailing PE ratio is 235.52.

PE Ratio	235.52
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.36
P/TBV Ratio	1.36
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	1.36
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.11, with a Debt / Equity ratio of 1.77.

Current Ratio	2.11
Quick Ratio	1.97
Debt / Equity	1.77
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-28.22%
Return on Invested Capital (ROIC)	-48.44%
Return on Capital Employed (ROCE)	-85.89%
Revenue Per Employee	n/a
Profits Per Employee	$708,262
Employee Count	103
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -61.40% in the last 52 weeks. The beta is 2.88, so MCRB's price volatility has been higher than the market average.

Beta (5Y)	2.88
52-Week Price Change	-61.40%
50-Day Moving Average	11.83
200-Day Moving Average	16.02
Relative Strength Index (RSI)	39.07
Average Volume (20 Days)	150,557

Short Selling Information

The latest short interest is 610,359, so 7.00% of the outstanding shares have been sold short.

Short Interest	610,359
Short Previous Month	15.26M
Short % of Shares Out	7.00%
Short % of Float	9.50%
Short Ratio (days to cover)	14.45

Income Statement

Revenue	n/a
Gross Profit	-10.38M
Operating Income	-114.11M
Pretax Income	-82.68M
Net Income	72.95M
EBITDA	-108.84M
EBIT	-114.11M
Earnings Per Share (EPS)	$0.03

Full Income Statement

Balance Sheet

The company has $58.85 million in cash and $89.55 million in debt, giving a net cash position of -$30.70 million or -$3.52 per share.

Cash & Cash Equivalents	58.85M
Total Debt	89.55M
Net Cash	-30.70M
Net Cash Per Share	-$3.52
Equity (Book Value)	50.47M
Book Value Per Share	5.78
Working Capital	34.76M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MCRB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-32,735.87%
Shareholder Yield	-32,735.87%
Earnings Yield	106.19%
FCF Yield	n/a

Analyst Forecast

The average price target for MCRB is $73.67, which is 835.49% higher than the current price. The consensus rating is "Hold".

Price Target	$73.67
Price Target Difference	835.49%
Analyst Consensus	Hold
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on April 22, 2025. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Apr 22, 2025
Split Type	Reverse
Split Ratio	0.05:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2